Skip to main content
. 2023 Dec 2;16:3901–3913. doi: 10.2147/DMSO.S439127

Table 1.

Comparative Clinical Characteristics of Low-Risk and Fibrosis-Risk Patients

Variable Low-Risk Group (n=346) Fibrosis-Risk Group (n=86) T/χ2/Z value P value
Age, years 50.34±8.75 51.16±8.93 0.774 0.440a
Male gender, n(%) 200 (57.8%) 45 (52.3%) 0.842 0.359b
Hypertension, n(%) 164 (47.4%) 45 (52.3%) 0.669 0.413b
Smoking, n(%) 82 (23.7%) 26 (30.2%) 1.568 0.211b
BMI, kg/m2 28.86±4.63 30.69±5.41 3.161 0.002a
Waist circumference, cm 96.44±15.24 99.56±11.49 1.778 0.076a
FBG, mmol/L 5.1 (3.7, 7.2) 6.2 (4.3, 7.8) 2.002 0.045c
HbA1c, % 6.9 (5.7, 8.2) 7.2 (5.7, 9.5) 2.247 0.025c
Triglycerides, mmol/L 1.66 (1.23, 2.64) 1.85 (1.24, 2.59) 0.276 0.782c
TC, mmol/L 4.00±1.30 3.91±1.45 0.522 0.602a
HDL-C, mmol/L 1.04±0.39 1.09±0.49 1.064 0.288a
LDL-C, mmol/L 2.47±0.83 2.62±0.70 1.618 0.106a
AST, IU/L 19 (13, 38) 19 (12, 29) 1.647 0.099c
ALT, IU/L 30 (12, 48) 37 (20, 73) 3.266 0.001c
ALB, IU/L 39.70±6.95 39.16±6.07 0.660 0.510a
PLT, ×109/L 250.75±47.92 228.92±51.38 3.727 <0.001a
HOMA-IR 1.8 (1.4, 2.2) 2.2 (1.7, 2.5) 3.787 <0.001c

Notes: afor independent sample t-test, bfor chi-square test, and cfor Mann–Whitney U-test.